MedTrace Logo

Eyelash Prostheses Compared to 5.0% Lifitegrast BID for Dry Eye Disease.

NCT03691636 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-10-02

No results posted yet for this study

Summary

This is a single-center, randomized, controlled trial to evaluate the safety and efficacy of eyelash prostheses versus 5.0% Lifitegrast BID, in 40 patients (20 randomized to each of two arms of the study) evaluated at 3 weeks and 5 weeks, respectively, after initiation of treatment.

Conditions

  • Dry Eye

Interventions

DEVICE

Eyelash prostheses

Eyelash prostheses are essentially specialized eyelash extensions

DEVICE

5.0% Lifitegrast Ophthalmic Solution

5.0% Lifitegrast Ophthalmic Solution

Sponsors & Collaborators

  • D.E.L., LLC

    lead INDUSTRY

Principal Investigators

  • Michael Korenfeld, MD · Comprehensive Eye Care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-02
Primary Completion
2019-04-02
Completion
2019-05-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03691636 on ClinicalTrials.gov